Report #2827357

Received Feb 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 62 yrs
State: MI
Recovered: Unknown
Vaccinated: Feb 9, 2025
Onset: Feb 9, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	X2FT9	—

Symptoms (1)

Expired product administered

Symptom narrative

expired vaccine used; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 62-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number X2FT9, expiry date 02-FEB-2025) for prophylaxis. On 09-FEB-2025, the patient received Arexvy. On 09-FEB-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: expired vaccine used). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 14-FEB-2025 Pharmacist called to report a male patient was administered an expired dose of an Arexvy vaccine. Pharmacist asked if there is any advice recommendation on this topic. Patient received expired dose of Arexvy vaccine, which led to expired vaccine used.